Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.1680
+0.0030 (1.82%)
Jul 21, 2026, 3:54 PM EDT - Market open
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $7.3 million as of July 21, 2026. Its market cap has decreased by -86.40% in one year.
Market Cap
7.30M
Enterprise Value
9.64M
1-Year Change
-86.40%
Ranking
Category
Stock Price
$0.17
ChartMarket Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $7.30M, a decrease of -94.49%. That is a compound annual growth rate of -83.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 7.30M | -79.22% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 8.04M |
| AEON Biopharma | 7.60M |
| Imunon | 7.44M |
| Can-Fite BioPharma | 7.31M |
| Kairos Pharma | 6.89M |
| PharmaCyte Biotech | 6.69M |
| Acurx Pharmaceuticals | 6.66M |
| XTL Biopharmaceuticals | 6.44M |